Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL4329 Target Snapshot

Kappa-type opioid receptor · SINGLE PROTEIN · Mus musculus

703Compounds
222Assays
14Approved Drugs
708.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P33534. Use UniProt P33534 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P33534 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Kappa-type opioid receptor as ChEMBL target CHEMBL4329, mapped to UniProt P33534. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Kappa-type opioid receptor
SINGLE PROTEIN · Mus musculus
As of 2026-09-14
ChEMBL target ID
CHEMBL4329
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P33534
Kappa-type opioid receptor
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Kappa-type opioid receptor is the right protein anchor across sources, using UniProt P33534 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelKappa-type opioid receptor
UniProt AccessionP33534
Component TypeProtein
Sequence Length380 aa

Kappa-type opioid receptor

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Kappa-type opioid receptor, mapped to UniProt P33534. Sequence length is 380 aa.

Mapped IDP33534
Review nameKappa-type opioid receptor
OrganismMus musculus
Clinical Profile

Clinical Phase Distribution

14
Approved
1
Phase II
2
Phase I
Assay Mix

Activity Type Distribution

IC5091.0
KI419.0
EC50163.0
KD35.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL4115374 10.92 EC50 0.012 Preclinical
CHEMBL489866 10.72 IC50 0.019 Preclinical
CHEMBL4115212 10.71 EC50 0.0194 Preclinical
CHEMBL4112945 10.68 EC50 0.021 Preclinical
CHEMBL4112470 10.67 EC50 0.0216 Preclinical
CHEMBL4112000 10.63 EC50 0.0234 Preclinical
CHEMBL4113007 10.55 EC50 0.028 Preclinical
CHEMBL1795711 10.52 Ki 0.03 Preclinical
CHEMBL4108145 10.5 EC50 0.0314 Preclinical
CHEMBL4108041 10.49 EC50 0.032 Preclinical
Distribution

pChEMBL Value Distribution

14
5.0
42
5.5
30
6.0
45
6.5
51
7.0
83
7.5
101
8.0
90
8.5
72
9.0
35
9.5
pChEMBL
Approved Drugs

Approved Drugs

DIFELIKEFALIN
CHEMBL3989915
Approved 2021
NALFURAFINE
CHEMBL267495
Approved 2009
NALFURAFINE HYDROCHLORIDE
CHEMBL490665
Approved 2009
LEVORPHANOL
CHEMBL592
Approved 1991
NALTREXONE
CHEMBL19019
Approved 1984
MORPHINE
CHEMBL70
Approved 1984
NALOXONE
CHEMBL80
Approved 1971
Assay Landscape

Assay Landscape

222
Total Assays
361
Tested Compounds
3
Assay Types
Functional — 123 assays, 173 compounds
BAO Format Assays Compounds Avg pChEMBL
cell membrane format 41 12 8.0
cell-based format 34 81 7.3
tissue-based format 21 41 8.6
assay format 19 39 9.8
organism-based format 8 0
Binding — 97 assays, 361 compounds
BAO Format Assays Compounds Avg pChEMBL
cell membrane format 54 129 8.0
single protein format 20 78 7.5
cell-based format 10 116 8.3
tissue-based format 9 10 6.9
assay format 4 28 7.5
ADME — 2 assays, 25 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 2 25 9.0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine